Skip to content

Clinical trials

Observational Hemophilia B trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Phase: Observational Country / region: Germany Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20082
20101
20142
20173
20181
20191
20201
20211
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Enrolling by invitation2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring3
Novo Nordisk A/S3
Swedish Orphan Biovitrum2
Wyeth is now a wholly owned subsidiary of Pfizer2
ApcinteX Ltd1
Baxalta now part of Shire1
Goethe University1
PedNet Haemophilia Research Foundation1
Pfizer1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B18
Hemophilia A9
Blood Coagulation Disorders2
Hematologic Diseases2
Blood Coagulation Disorders, Inherited1
Coagulation Protein Disorders1
Genetic Diseases, Inborn1
Hemorrhagic Disorders1
Hypersensitivity1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.